Danielle Rebibo

646 total citations
20 papers, 482 citations indexed

About

Danielle Rebibo is a scholar working on Management of Technology and Innovation, Biochemistry and Hematology. According to data from OpenAlex, Danielle Rebibo has authored 20 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Management of Technology and Innovation, 13 papers in Biochemistry and 6 papers in Hematology. Recurrent topics in Danielle Rebibo's work include Blood transfusion and management (13 papers), Blood donation and transfusion practices (13 papers) and Blood groups and transfusion (6 papers). Danielle Rebibo is often cited by papers focused on Blood transfusion and management (13 papers), Blood donation and transfusion practices (13 papers) and Blood groups and transfusion (6 papers). Danielle Rebibo collaborates with scholars based in France and United States. Danielle Rebibo's co-authors include Georges Andreu, Patrick Hervé, Pascal Morel, G Janvier, François Forestier, J Debeir, C. Caldani, P. Renaudier, Paul‐Michel Mertès and Jean‐Yves Muller and has published in prestigious journals such as Blood, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Danielle Rebibo

20 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Rebibo France 10 339 228 166 128 47 20 482
Alexandra Gray United Kingdom 7 279 0.8× 161 0.7× 145 0.9× 132 1.0× 36 0.8× 10 415
L. M. Williamson United Kingdom 10 259 0.8× 130 0.6× 115 0.7× 200 1.6× 43 0.9× 14 477
Dan A. Waxman United States 10 113 0.3× 105 0.5× 66 0.4× 77 0.6× 38 0.8× 22 336
Srijana Rajbhandary United States 8 181 0.5× 121 0.5× 90 0.5× 66 0.5× 72 1.5× 17 335
Clare Milkins United Kingdom 10 353 1.0× 186 0.8× 149 0.9× 377 2.9× 49 1.0× 13 684
Camila Caram‐Deelder Netherlands 15 147 0.4× 65 0.3× 166 1.0× 165 1.3× 42 0.9× 48 504
Misha L. Baker United States 7 221 0.7× 172 0.8× 94 0.6× 96 0.8× 45 1.0× 8 367
Elsa Tynell Sweden 11 129 0.4× 105 0.5× 96 0.6× 62 0.5× 180 3.8× 16 496
Suzanne H. Butch United States 12 179 0.5× 88 0.4× 45 0.3× 175 1.4× 27 0.6× 26 423
J. McCullough Netherlands 4 200 0.6× 52 0.2× 49 0.3× 265 2.1× 45 1.0× 5 450

Countries citing papers authored by Danielle Rebibo

Since Specialization
Citations

This map shows the geographic impact of Danielle Rebibo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Rebibo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Rebibo more than expected).

Fields of papers citing papers by Danielle Rebibo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Rebibo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Rebibo. The network helps show where Danielle Rebibo may publish in the future.

Co-authorship network of co-authors of Danielle Rebibo

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Rebibo. A scholar is included among the top collaborators of Danielle Rebibo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Rebibo. Danielle Rebibo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lafeuillade, Bruno, François Eb, Rachel Petermann, et al.. (2014). Residual risk and retrospective analysis of transfusion‐transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008. Transfusion. 55(3). 636–646. 38 indexed citations
2.
Ozier, Yves, Jean‐Yves Muller, Paul‐Michel Mertès, et al.. (2011). Transfusion‐related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008. Transfusion. 51(10). 2102–2110. 46 indexed citations
3.
Mertès, Paul‐Michel, François Alla, Jacques Bienvenu, et al.. (2011). Hypersensitivity reactions to blood components: document issued by the allergy committee of the French medicines and healthcare products regulatory agency.. PubMed. 21(3). 171–8. 24 indexed citations
4.
Ozier, Yves, P. Renaudier, C. Caldani, et al.. (2010). Œdèmes pulmonaires transfusionnels : classification des cas notifiés en hémovigilance. Transfusion Clinique et Biologique. 17(5-6). 284–290. 4 indexed citations
5.
Isola, Hervé, et al.. (2010). La gestion des informations post-don : un élément fondamental de la sécurité transfusionnelle. Transfusion Clinique et Biologique. 17(5-6). 296–300. 6 indexed citations
6.
Auroy, Yves, G. Andreu, Dan Benhamou, et al.. (2010). Sécurité des patients et analyse des causes racines. Transfusion Clinique et Biologique. 17(5-6). 386–389. 3 indexed citations
7.
Rebibo, Danielle, et al.. (2010). Transfusion et risques résiduels. Revue Francophone des Laboratoires. 2010(426). 79–83. 4 indexed citations
8.
Renaudier, P., et al.. (2009). Complications pulmonaires de la transfusion (TACO–TRALI). Transfusion Clinique et Biologique. 16(2). 218–232. 18 indexed citations
9.
Renaudier, P., et al.. (2008). Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results. Transfusion Medicine and Hemotherapy. 35(2). 89–91. 6 indexed citations
10.
Rebibo, Danielle, et al.. (2008). L’introduction de solutions de conservation dans les concentrés plaquettaires : vers une diminution des réactions transfusionnelles. Transfusion Clinique et Biologique. 15(5). 289–293. 9 indexed citations
11.
Rebibo, Danielle & Bruno Danic. (2007). Hémovigilance donneurs : modalités et résultats. Transfusion Clinique et Biologique. 14(1). 142–146. 7 indexed citations
12.
Renaudier, P., et al.. (2007). The Declining Risk of ABO Incompatibilities: Twelve Years of Hemovigilance in France.. Blood. 110(11). 2891–2891. 1 indexed citations
13.
Verdier, Philippe, Patricia Fromont, Jean‐Yves Muller, et al.. (2005). Transfusion Related Acute Lung Injury (TRALI) Caused by Red Blood Cell Transfusion Involving Residual Plasma Anti‐HLA Antibodies: A report on two Cases and General Considerations. Journal of Immunology Research. 12(4). 243–248. 11 indexed citations
14.
Rebibo, Danielle, et al.. (2004). The French Haemovigilance System: organization and results for 2003. Transfusion and Apheresis Science. 31(2). 145–153. 52 indexed citations
15.
Andreu, Georges, Pascal Morel, François Forestier, et al.. (2002). Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion. 42(10). 1356–1364. 214 indexed citations
16.
Rebibo, Danielle, et al.. (2001). [Blood transfusion surveillance: organization and results].. PubMed. 51(12). 1332–6. 1 indexed citations
17.
Hervé, Patrick, et al.. (2000). Hemovigilance in France. Revista Brasileira de Hematologia e Hemoterapia. 22(3). 8 indexed citations
18.
Copie‐Bergman, Christiane, Bruno Falissard, Jean Philippe Jaïs, et al.. (1996). TCR αβ gene usage for myelin basic protein recognition in healthy monozygous twins. The Journal of Immunology. 156(10). 3747–3754. 9 indexed citations
19.
Copie‐Bergman, Christiane, George A. Hashim, Danielle Rebibo, et al.. (1994). Healthy monozygous twins do not recognize identical T cell epitopes on the myelin basic protein autoantigen. European Journal of Immunology. 24(10). 2299–2303. 13 indexed citations
20.
Girot, Robert, et al.. (1986). Neocytopheresis: a new approach for the transfusion of patients with thalassaemia major. European Journal of Pediatrics. 145(1-2). 10–13. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandra Gray Breakdown of academic impact, for papers by L. M. Williamson Breakdown of academic impact, for papers by Dan A. Waxman Breakdown of academic impact, for papers by Srijana Rajbhandary Breakdown of academic impact, for papers by Clare Milkins Breakdown of academic impact, for papers by Camila Caram‐Deelder Breakdown of academic impact, for papers by Misha L. Baker Breakdown of academic impact, for papers by Elsa Tynell Breakdown of academic impact, for papers by Suzanne H. Butch Breakdown of academic impact, for papers by J. McCullough
Rankless by CCL
2026